Recombinant Methioninase as a DNA Demethylation Agent.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2019
Historique:
entrez: 7 2 2019
pubmed: 7 2 2019
medline: 28 5 2019
Statut: ppublish

Résumé

This chapter reviews the effect of methionine (MET) restriction, via treatment with recombinant methioninase (rMETase), on DNA methylation of cancer cells. CCRF-CEM human cancer cells were treated with rMETase under subcytotoxic conditions. The rMETase-treated cells contained significantly lower levels of genomic methylated DNA than did untreated control cells. DNA methylation was measured by incorporation of the methyl group of [

Identifiants

pubmed: 30725424
doi: 10.1007/978-1-4939-8796-2_22
doi:

Substances chimiques

Recombinant Proteins 0
Carbon-Sulfur Lyases EC 4.4.-
L-methionine gamma-lyase EC 4.4.1.11
Azacitidine M801H13NRU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

279-284

Auteurs

Robert M Hoffman (RM)

AntiCancer, Inc., San Diego, CA, USA. all@anticancer.com.
Department of Surgery, University of California, San Diego, CA, USA. all@anticancer.com.

David Machover (D)

Hopital Paul Brousse, Villejuif Cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH